Skip to main content
PolicySpeak
← All files
ERA

ErasmusMC

Academic / research · Netherlands

3
positions filed
in the 665 files tracked
2
legislative files
of 665 tracked
1
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.

Track ErasmusMC in PolicySpeak: request access →

Follow ErasmusMC

An email when this organization files on a consultation we publish.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Work at ErasmusMC? so we know who speaks for it.

Their record over time

ErasmusMC filed 3 positions between 1 Oct 2025 and 21 Jul 2026, across 2 of the 665 legislative files tracked here, attaching a full position paper 1 time.

2025 · 2 filed2026 · 1 filed

What they argued

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 21 Jul 2026source

On behalf of Viroscience diagnostic laboratory at the Erasmus MC, Rotterdam, we welcome the proposed amendments to the In Vitro Diagnostic Medical Devices Regulation (IVDR) and strongly support their incorporation into the revised regulatory framework. The proposed changes will improve the flexibility, sustainability, and resilience of diagnostic services across the European Union.

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 1 Oct 2025source

I'm representing the Dutch IVDR taskforce in which representatives of medical diagnostic laboratories working in the field of clinical chemistry, immunology, microbiology, pathology, genetics and pharmacy work together to advise diagnostic laboratories in the Netherlands on how to implement IVDR for laboratory-developed tests.

European Competitiveness Fundfiled 11 Nov 2025PDFsource

Explicit inclusion of European Reference Networks (ERNs) in the ECF is vital for health competitiveness and rare disease care The current proposal for the European Competitiveness Fund (ECF), specifically Chapter V (Articles 36 and 37) on Health, biotech, agriculture and bioeconomy, aligns perfectly with the mission of European Reference Networks (ERNs).

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put ErasmusMC next to another organization. Same files, same register facts, side by side. Compare →

Turns up on the same files

Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.

Showing 5 of 16.

Is this your organization?

Everything on this page comes from ErasmusMC’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.